Key TakeawaysTotal 2025 revenue rose 11% to $274.9B and adjusted EPS grew 9% to $29.84, with 2026 adjusted EPS guidance of at least $30.25.Evernorth outperformed with Express Scripts adjusted revenue up 18% and specialty/care services up 14%, supported by volume growth and increasing biosimilar adoption.Cigna Healthcare revenue fell 11% primarily from the HCSC Medicare divestiture; […]
